ES2194696T3 - Compuestos quimicos. - Google Patents
Compuestos quimicos.Info
- Publication number
- ES2194696T3 ES2194696T3 ES00900636T ES00900636T ES2194696T3 ES 2194696 T3 ES2194696 T3 ES 2194696T3 ES 00900636 T ES00900636 T ES 00900636T ES 00900636 T ES00900636 T ES 00900636T ES 2194696 T3 ES2194696 T3 ES 2194696T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- chemical compounds
- alkyl group
- atom
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuesto que responde a la fórmula general (I) **(Fórmula)** en la que: X representa un átomo de hidrógeno o de halógeno, Y representa uno o varios átomos o grupos elegidos entre el hidrógeno, los halógenos y los grupos metilo, metoxi y nitro, R1 representa un grupo (C1-C4) alquilo, R2 y R3 representan, cada uno, independientemente uno de otro, un átomo de hidrógeno o un grupo (C1C4 )alquilo, o bien R2 y R3 forman, con el átomo de nitrógeno que los lleva, un grupo pirrolidinilo, piperidinilo o morfolinilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9900805A FR2788776B1 (fr) | 1999-01-26 | 1999-01-26 | Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2194696T3 true ES2194696T3 (es) | 2003-12-01 |
Family
ID=9541211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES00900636T Expired - Lifetime ES2194696T3 (es) | 1999-01-26 | 2000-01-21 | Compuestos quimicos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6451795B1 (es) |
EP (1) | EP1149101B1 (es) |
JP (1) | JP4574860B2 (es) |
AR (1) | AR030016A1 (es) |
AT (1) | ATE236905T1 (es) |
AU (1) | AU3057800A (es) |
CO (1) | CO5160255A1 (es) |
DE (1) | DE60002043T2 (es) |
ES (1) | ES2194696T3 (es) |
FR (1) | FR2788776B1 (es) |
WO (1) | WO2000044751A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2788696B1 (fr) * | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
FR2811990A1 (fr) * | 2000-07-24 | 2002-01-25 | Sanofi Synthelabo | DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2833953B1 (fr) | 2001-12-21 | 2004-12-03 | Sanofi Synthelabo | DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2838124B1 (fr) * | 2002-04-03 | 2004-05-28 | Sanofi Synthelabo | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique |
GB0523506D0 (en) * | 2005-11-18 | 2005-12-28 | Hammersmith Imanet Ltd | Novel in vivo imaging compounds |
GB0818738D0 (en) * | 2008-10-13 | 2008-11-19 | Ge Healthcare Ltd | Imaging neuroflammation |
GB0905328D0 (en) * | 2009-03-27 | 2009-05-13 | Ge Healthcare Ltd | Indole derivatives |
ES2688574T3 (es) * | 2010-03-26 | 2018-11-05 | Ge Healthcare Limited | Derivados de indol tricíclicos como ligandos de PBR |
US9220795B2 (en) | 2011-09-22 | 2015-12-29 | Ge Healthcare Limited | Indole derivatives |
GB201312768D0 (en) | 2013-07-17 | 2013-08-28 | Ge Healthcare Ltd | Work-up procedure |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9109972D0 (en) * | 1991-05-09 | 1991-07-03 | Ici Plc | Therapeutic compounds |
GB9411955D0 (en) * | 1994-06-15 | 1994-08-03 | Merck Sharp & Dohme | Therapeutic agents |
FR2754262B1 (fr) * | 1996-10-08 | 1998-10-30 | Synthelabo | Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique |
FR2766823B1 (fr) * | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
-
1999
- 1999-01-26 FR FR9900805A patent/FR2788776B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-21 ES ES00900636T patent/ES2194696T3/es not_active Expired - Lifetime
- 2000-01-21 AU AU30578/00A patent/AU3057800A/en not_active Abandoned
- 2000-01-21 US US09/889,984 patent/US6451795B1/en not_active Expired - Fee Related
- 2000-01-21 DE DE60002043T patent/DE60002043T2/de not_active Expired - Lifetime
- 2000-01-21 EP EP00900636A patent/EP1149101B1/fr not_active Expired - Lifetime
- 2000-01-21 AT AT00900636T patent/ATE236905T1/de active
- 2000-01-21 JP JP2000596007A patent/JP4574860B2/ja not_active Expired - Fee Related
- 2000-01-21 WO PCT/FR2000/000134 patent/WO2000044751A1/fr active IP Right Grant
- 2000-01-25 AR ARP000100304A patent/AR030016A1/es unknown
- 2000-01-25 CO CO00003864A patent/CO5160255A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002535406A (ja) | 2002-10-22 |
DE60002043T2 (de) | 2004-02-19 |
FR2788776B1 (fr) | 2001-02-23 |
JP4574860B2 (ja) | 2010-11-04 |
ATE236905T1 (de) | 2003-04-15 |
EP1149101A1 (fr) | 2001-10-31 |
FR2788776A1 (fr) | 2000-07-28 |
CO5160255A1 (es) | 2002-05-30 |
WO2000044751A1 (fr) | 2000-08-03 |
AR030016A1 (es) | 2003-08-13 |
DE60002043D1 (de) | 2003-05-15 |
AU3057800A (en) | 2000-08-18 |
EP1149101B1 (fr) | 2003-04-09 |
US6451795B1 (en) | 2002-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP045369A (es) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
NO20052469L (no) | Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2. | |
SE9904652D0 (sv) | Novel Compounds | |
CO5601018A2 (es) | Derivados de n-fenil-2-pirimidin-amina | |
NO20032252D0 (no) | Piperazinylpyrazinforbindelser som agonist eller antagonist av serotonin 5HT-2-reseptor | |
TR200001937T2 (tr) | Kimyasal bileşikler. | |
ES2189726T3 (es) | Isoxazolidinas sustituidas con heterociclo y su uso como fungicidas. | |
ES2192520T3 (es) | Composicion farmaceutica. | |
ECSP099395A (es) | Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico | |
ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
ES2194696T3 (es) | Compuestos quimicos. | |
CO6150147A2 (es) | Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii | |
TW200508359A (en) | Quinoxaline derivatives, and light emitting element using thereof | |
AR036472A1 (es) | Derivados de azetidina, procedimientos para su preparacion y su empleo como agentes pesticidas | |
AR053559A1 (es) | Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados | |
CO5210883A1 (es) | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO [4,5,-b]INDOL- 1-ACETAMIDA | |
AR004965A1 (es) | Procedimiento de preparacion de derivados de fenilimidazolidina | |
ES2177275T3 (es) | Derivados de oxadiazolina y su uso como insecticidas. | |
NO20061344L (no) | Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer | |
NO20043928L (no) | Komponentholder og radioisotopgenerator med en eller flere komponentholdere | |
CO4520266A1 (es) | Derivado de 1,3-oxazin-4-ona, el herbicida que lo contiene y los productos intermedios para prepararlo | |
PA8437201A1 (es) | Compuestos de pirrolidinil y pirrolinil etilamina como agonistas kappa. | |
MXPA04009421A (es) | Compuestos de tiazol-2-ilimina como inhibidores de la pde-7. | |
AR012730A1 (es) | Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario | |
AR029468A1 (es) | Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |